News

£600k grant funding from Innovate UK To validate the NeuroMotor PenTM for screening of dementias and cognitive im-pairment

April 20, 2021

Edinburgh, UK – 20 April 2021: Manus Neurodynamica Limited (“Manus”), which develops and markets products and technologies for neuromotor assessment, has received £600,000 grant funding from Innovate UK, to optimise and validate the NeuroMotor PenTM (NMP) for screening of dementias and cognitive impairment, over a two-year project. Only around … Read more

Ex-Siemens Business Development Manager joins Manus

March 18, 2021

Manus Neurodynamica Limited Ex-Siemens Business Development Manager joins Manus Director of Commercial Growth appointed to execute sales and marketing strategy Edinburgh, UK – 18 March 2021: Manus Neurodynamica Limited (“Manus”), which develops and markets products and technologies for neuromotor assessment, announces the appointment of Euan Donald as Director of … Read more

MANUS NEURODYNAMICA LIMITED NeuroMotor Pen™ Differentiates Parkinson’s from other tremors; Regulatory submission in the USA

February 16, 2021

Edinburgh, UK – 16 February 2021: Manus Neurodynamica Limited (“Manus”), which develops and markets products and technologies for neuromotor assessment, announces the results of a clinical study to validate the Manus system’s ability to distinguish Parkinson’s Disease (PD) from other movement disorders. The study was conducted at Northumbria Healthcare … Read more

MANUS NEURODYNAMICA LIMITED NeuroMotor Pen™ predictive of side effects of anti-psychotics

February 1, 2021

Edinburgh, UK – 1 February 2021: Manus Neurodynamica Limited (“Manus”), which develops and markets products and technologies for neuromotor assessment, announces the results of a clinical study to evaluate the utility of the Manus system in the assessment of the extrapyramidal adverse effects of antipsychotic drugs conducted in collaboration … Read more

Manus secures £1.2m to support launch of Parkinson’s Pen

January 25, 2021

Edinburgh, UK – Monday 25th January 2021:  Edinburgh medtech company Manus Neurodynamica Limited (“Manus”), has closed a £1.2M funding round to support the launch of its digital pen which provides an early warning of Parkinson’s disease and other neurological conditions. With this latest funding secured, Manus is rolling-out its NeuroMotor … Read more

£750,000 investment to support commercial roll-out of NeuroMotor PenTM

June 3, 2020

Manus Neurodynamica Limited £750,000 investment in Parkinson’s diagnostic Scottish funds to support commercial roll-out of NeuroMotor PenTM Edinburgh, UK – 3 June 2020:  Manus Neurodynamica Limited (“Manus”), which develops and markets products for neuromotor assessment, including the NeuroMotor PenTM– a platform technology that can diagnose Parkinson’s disease and other … Read more

Manus Manufacturing Agreement

January 18, 2020

Manus Neurodynamica Limited Writing instrument giant STABILO to make Manus’ diagnostic pen Edinburgh, UK – 18th January 2020: MANUS Neurodynamica Limited (“Manus”), which develops and markets products and technologies for neuromotor assessment, announces a five-year manufacturing and supply agreement with STABILO International GmbH (“STABILO”) for its digital pen. STABILO … Read more

Digital Health Society Summit “Connecting Digital Health & Data Initiatives in Europe” December 2019

December 17, 2019

Manus Neurodynamica and the NeuroMotor Pen were also presented at The Digital Health Society Summit – “Connecting Digital Health & Data Initiatives in Europe”. The event was a two-day forum about data-driven transformation of health and social care, and it took place in Helsinki, Finland, on December 12th, 2019. … Read more

MEDICA Trade Fair in Düsseldorf November 2019

December 17, 2019

Our CEO, Rutger Zietsma, with our Non-Executive Director, Keith Redpath, represented Manus Neurodynamica at MEDICA 2019, which took place on November 18-21 in Düsseldorf, Germany, at the Scottish Enterprise pavilion. MEDICA is known as the world leading trade fair for medical technology, electromedical equipment, laboratory equipment, diagnostics. It attracts … Read more

Congress of Movement Disorders in Nice September 2019

December 17, 2019

Manus Neurodynamica held an opinion leader advisory group (OLAG) meeting at the International Congress and Parkinson’s Disease and Movement Disorders that took place at the Acropolis Centre in Nice, France, on September 22-26, 2019. The conference, organized by the Movement Disorder Society (MDS), is an annual educational forum for … Read more